Cite
HARVARD Citation
Escobar, M. et al. (2021). PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors. Haemophilia. 27 (6), pp. 911-920. [Online].